Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Web based Research Platforms facilitating clinical cytogenetic research

RESULT DESCRIPTION:
ECARUCA will create a platform for exchanging clinical information on rare (sub)microscopic chromosomal aberrations which can be used for research related purposes as well.

DISSEMINATION:
The accountholders will be able to visit the specific websites of the research platforms. The accountholders will also be frequently informed on new changes within those research platforms. Moreover, those with a specific research interest will be encouraged to moderate a research website related to the topic of their interest.

INNOVATIVE FEATURES:
Bringing together researchers in the field of cytogenetics through a web based application is new and will both initiate and facilitate new European collaborative research activities.

CURRENT STATUS AND THE USE OF RESULTS:
In the near future, it will be possible for all ECARUCA account holders to announce their special research/clinical interest related to a specific chromosome region. The latter will be done by creating web pages, linked to the ECARUCA website, for the announcement of special research interests and calls for collaboration. The lay-out of webpages are, currently, being developed for several groups of aberrations including telomeric and interstitial submicroscopic aberrations.

EXPECTED BENEFITS:
New collaborations on specific chromosome regions between various European groups. This will lead to a better insight of the origin, frequency and clinical significance of specific (rare) chromosomal abnormalities. This will lead to a better care of the patients with these specific chromosome aberrations and information to the families and professionals involved.

Informazioni correlate

Reported by

NATIONAL GENETICS REFERENCE LABORATORY(WESSEX)
Dept. Human Genetics 849, P.O. Box 9101
6500 HB Salisbury
United Kingdom